Latest Breast cancer screening Stories

Mammograms might benefit women in their 40s with family history or dense breasts Choosing when to start regular breast cancer screening is a complicated decision for individual women and their providers. For most women, increasing age is the biggest risk factor for breast cancer, which is much more common at age 60 than at 40. But two new articles on other risk factors may inform guidelines and clinical practice about screening mammography from age 40 to 49. The articles in the May 1...

A new analysis suggests the benefits of mammography screening every other year outweigh the potential harms for women aged 40 to 49 who are at an increased risk of developing breast cancer -- a finding that could affect one out of every five American women. The researchers also found greater harms from screening done with digital mammography compared to film mammography. These findings, with contributions from three national research groups, are published in the May 1 issue of Annals of...

A new study from researchers at the Bangkok Breast Center shows significant improvement in the detection of breast cancer in Asian women using automated breast volume sonography (ABVS) as compared to hand-held ultrasound (HHUS). In their study on 504 findings in 212 patients at the Bangkok Breast Center, researchers found that ABVS agreed with HHUS in detecting 15 suspicious lesions, uncovered 12 additional suspicious lesions, and excluded 3 suspicious lesions in these cases. A...

Researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine have published new findings that mammography remains beneficial for women in their 40s. According to a study published in the May issue of American Journal of Roentgenology, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors than symptomatic women needing diagnostic workup. The paper comes on the...

SACRAMENTO, Calif., April 18, 2012 /PRNewswire/ -- In an announcement today by the National Hispanic Christian Leadership Conference (www.NHCLC.org), also known as the Hispanic Evangelical Association, the nation's largest Christian Hispanic organization, the National Breast Cancer Foundation, Inc. (NBCF) will serve as the Senior Partner of the NHCLC's Healthy Families Directive -- partnering to save women's lives. Rev. Samuel Rodriguez, President of the NHCLC, said, "The heart...

Women who receive “false-positive” mammography results may be at higher risk of breast cancer later in life, a new study suggests. The Danish study of more than 58,000 women found that those with mammogram results initially suggesting breast cancer, although none was present, had a 67 percent greater risk of developing breast cancer compared with women with negative mammograms. Screening mammography can sometimes produce false-positive results in disease-free women.  Suspicious...

The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study in the April 4 issue of JAMA. "Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on mammography. Magnetic resonance imaging may reveal additional breast cancers missed by both mammography and...

Late-stage disease incidence not reduced by screening New Harvard School of Public Health (HSPH) research suggests that routine mammography screening—long viewed as an essential tool in detecting early breast cancers—may in fact lead to a significant amount of overdiagnosis of disease that would otherwise have proved harmless. Based on a study of women in Norway, the researchers estimate that between 15% and 25% of breast cancer cases are overdiagnosed. The study appears in the...

Matakina International Limited announced that it has been granted a medical device license by the Medical Devices Bureau of Health Canada to sell and market the Volpara breast imaging software in Canada. WELLINGTON, New Zealand (PRWEB) March 21, 2012 Matakina International Limited of Wellington, New Zealand, today announced that it has been granted a medical device license by the Medical Devices Bureau of Health Canada to sell and market the Volpara breast imaging software in Canada....

A Dutch study of the effectiveness of breast cancer screening shows that, even with improved treatments for the disease, population-based mammography programs still save a significant number of lives. The finding, presented today (Wednesday) at the eighth European Breast Cancer Conference (EBCC-8) in Vienna, will add further fuel to the debate about whether or not breast cancer screening does more harm than good. Those who argue against national screening programs say that treatment for...